Bacil Pharma’s wholly owned subsidiary -- Bacil Research and Development has entered into an agreement with Efdee Pharma for undertaking research and development activities relating to pharmaceutical products. The project shall involve research and development of pharmaceutical products, including pellets, granules, powders, tablets and capsules. The total estimated cost of the project shall be Rs 35 crore.
Bacil Pharma is primarily engaged in healthcare solutions focusing on the development, manufacturing, and distribution of pharmaceutical formulations including tablets, capsules, ointments, injectables, and specialty products. All operations comply with the relevant regulatory and quality standards.
